Halozyme Appoints Dannielle Appelhans to its Board of Directors

Go back to Halozyme Appoints Dannielle Appelhans to its Board of Directors
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 108.08 +1.96 (1.85%)
Previous Close $106.12    52 Week High $18.39 
Open $106.20    52 Week Low $6.96 
Day High $108.39    P/E N/A 
Day Low $105.91    EPS $-0.58 
Volume 419,737